Vir Biotechnology, Inc. · BX:VIR

Vir Biotechnology, Inc. financial statements

Vir Biotechnology, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue68.6M74.2M86.2M1.62B1.10B76.4M8.09M10.7M2.71M
Cost of revenue26.0K845.0K2.77M146.3M65.9M00100.2M62.5M
Gross profit56.9M58.8M64.0M1.45B1.02B76.4M711.0K-99.4M-62.4M
Research and development456.0M506.5M579.7M474.6M448.0M302.4M148.5M100.2M62.5M
Selling, general and administrative92.1M119.0M174.4M161.8M160.8M70.9M37.6M29.1M21.7M
Operating income-479.3M-587.2M-684.3M833.1M420.8M-297.0M-178.0M-118.7M-81.5M
Depreciation and amortization11.7M14.6M19.5M6.78M5.28M4.40M3.29M1.62M255.0K
EBITDA-467.6M-572.6M-664.9M839.9M426.0M-292.6M-174.7M-117.1M-81.2M
Interest expense183.1M272.9M3.81M7.97M00
Income before tax-437.8M-523.1M-628.2M754.3M549.8M-298.6M-174.5M-116.4M-80.8M
Income tax217.0K-1.15M-13.1M238.4M21.2M54.0K154.0K-480.0K-10.9M
Net income-438.0M-522.0M-615.1M515.8M528.6M-298.7M-174.7M-115.9M-69.9M
Earnings per share, basic-3.16-3.83-4.593.894.07-2.51-5.76-15.12-32.45
Earnings per share, diluted-3.16-3.83-4.593.833.96-2.51-5.76-15.12-32.45

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents232.2M222.9M241.6M848.6M347.8M436.6M109.3M47.6M187.9M
Short-term investments228.8M678.1M1.27B1.52B217.2M300.3M274.1M50.8M0
Receivables3.60M5.10M11.6M0773.1M0
Inventory8.59M00
Current assets514.1M1.04B1.59B2.52B1.56B772.4M403.0M117.8M192.3M
Property, plant and equipment55.6M63.2M96.0M105.6M42.8M17.9M16.3M12.3M5.14M
Goodwill16.9M16.9M16.9M16.9M16.9M16.9M16.9M16.9M16.9M
Total assets1.00B1.40B1.92B2.80B1.95B918.8M512.1M191.6M251.6M
Accounts payable9.80M5.08M6.33M6.42M6.52M5.08M5.88M6.47M4.90M
Current liabilities92.8M119.7M175.4M511.0M341.2M99.1M59.2M39.9M12.4M
Long-term debt00
Total debt186.9M97.9M124.5M128.0M137.5M70.2M1.14M10.1M
Total liabilities237.5M248.4M328.8M724.1M522.4M201.9M88.1M61.6M320.5M
Shareholders' equity765.3M1.15B1.59B2.08B1.43B716.9M423.9M-179.2M-68.9M
Shares outstanding139.5M137.0M134.8M133.2M131.2M127.4M107.6M8.86M127.8M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-391.8M-446.4M-778.8M1.66B-47.6M-190.9M-129.6M-94.1M-66.4M
Capital spending-4.83M-7.30M-21.6M-68.0M-21.8M-6.55M-8.94M-8.19M-2.74M
Free cash flow-396.6M-453.7M-800.4M1.60B-69.4M-197.5M-138.6M-102.3M-69.1M
Cash from investing310.4M499.4M164.6M-1.19B-140.8M-9.86M-256.2M-60.4M-30.0M
Cash from financing3.79M4.39M7.48M34.8M100.3M529.5M449.2M25.0M271.2M
Dividends paid00
Share buybacks3.22M15.4M327.3M-3.00K14.8M0
Change in cash-77.6M57.4M-606.7M504.6M-88.1M328.7M63.5M-129.6M174.8M